You have 9 free searches left this month | for more free features.

Ombitasvir/Paritaprevir/Ritonavir dasabuvir

Showing 26 - 50 of 823

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

ABT-450/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic

Completed
  • Chronic Hepatitis C
  • (no location specified)
May 1, 2019

Hepatitis C, Chronic Trial in Sydney ("3D" regimen, "3D" regimen with ribavirin)

Completed
  • Hepatitis C, Chronic
  • "3D" regimen
  • "3D" regimen with ribavirin
  • Sydney, New South Wales, Australia
    The Kirby Institute, University of New South Wales Australia
Jun 11, 2019

Hepatitis C Virus Trial (Paritaprevir, Ritonavir, Dasabuvir)

Unknown status
  • Hepatitis C Virus
  • (no location specified)
Oct 4, 2019

Hepatitis C Virus Infection Trial (OBV/PTV/r) ± ribavirin (RBV))

Completed
  • Hepatitis C Virus Infection
  • OBV/PTV/r) ± ribavirin (RBV)
  • (no location specified)
May 9, 2020

Hepatitis C Virus Trial (ABT-450/r/ABT-267, Ribavirin)

Completed
  • Hepatitis C Virus
  • (no location specified)
Jul 28, 2021

Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic

Completed
  • Chronic Hepatitis C
  • (no location specified)
Mar 26, 2019

Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic

Completed
  • Chronic Hepatitis C
  • (no location specified)
Oct 22, 2018

HCV Coinfection Trial in Afula (VEKIRAX, EXVIERA)

Completed
  • HCV Coinfection
  • Afula, Israel
    Haemek medical center
Aug 8, 2019

Chronic Hepatitis C Virus Infection Trial in Beni-Suef (SOF plus (OBV/PTV/r) plus RBV)

Completed
  • Chronic Hepatitis C Virus Infection
  • SOF plus (OBV/PTV/r) plus RBV
  • Beni-Suef, Egypt
    Beni-Suef University
May 13, 2020

Viekira/Exviera for Korean Hepatitis C Patients According to

Completed
  • Hepatitis C Virus (HCV)
    • Busan, Busan Gwang Yeogsi, Korea, Republic of
    • +58 more
    Oct 6, 2020

    Paritaprevir/Ritonavir, Ombitasvir, + Dasabuvir, ± Ribavirin in

    Completed
    • Chronic Hepatitis C
      • (no location specified)
      Aug 2, 2018

      Resistance to AbbVie's 2 Direct-acting Antiviral Agent Therapy

      Completed
      • Hepatitis C Virus
        • Nagoya-shi, Aichi, Japan
        • +52 more
        Dec 6, 2021

        Hepatitis Viruses Trial in Taiwan (PTV/r/OBV/DSV)

        Completed
        • Hepatitis Viruses
        • Chiayi City, Taiwan
        • +7 more
        May 10, 2019

        Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic

        Completed
        • Chronic Hepatitis C
          • (no location specified)
          May 23, 2019

          End-stage Renal Disease, HCV Coinfection Trial in Assiut (Ombitasvir / Paritaprevir / Ritonavir /Ribavirin Oral Tablet)

          Completed
          • End-stage Renal Disease
          • HCV Coinfection
          • Ombitasvir / Paritaprevir / Ritonavir /Ribavirin Oral Tablet
          • Assiut, Egypt
            Assiut University Hopsital
          Jan 8, 2020

          Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic

          Completed
          • Chronic Hepatitis C
            • (no location specified)
            Sep 16, 2019

            Paritaprevir/Ritonavir - Ombitasvir, + Dasabuvir Without

            Completed
            • Chronic Hepatitis C
              • Chelyabinsk, Russian Federation
              • +6 more
              Nov 20, 2018

              Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic

              Completed
              • Chronic Hepatitis C
                • Bogotá, Colombia
                • +5 more
                Aug 12, 2019

                Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic

                Completed
                • Chronic Hepatitis C
                  • (no location specified)
                  Feb 28, 2019

                  Paritaprevir/Ritonavir, Ombitasvir, ± Dasabuvir, ± Ribavirin in

                  Completed
                  • Chronic Hepatitis C
                    • (no location specified)
                    Mar 21, 2018

                    Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and

                    Completed
                    • Chronic Hepatitis C
                      • Dordrecht, Zuid-Holland, Netherlands
                      • +8 more
                      May 15, 2019

                      Clinical Outcomes of Paritaprevir/Ombitasvir/r+Dasabuvir 8 Weeks

                      Completed
                      • Hepatitis C Infection
                      • ombitasvir/paritaprevir/ritonavir 8 weeks
                      • dasabuvir 8 weeks
                      • Barcelona, Spain
                        Carrion, Jose Antonio, PhD
                      May 18, 2018

                      Chronic Hepatitis C Trial (paritaprevir/ritonavir/ombitasvir + dasabuvir +/- ribavirin)

                      Completed
                      • Chronic Hepatitis C
                      • paritaprevir/ritonavir/ombitasvir + dasabuvir +/- ribavirin
                      • (no location specified)
                      Oct 17, 2018

                      Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in

                      Completed
                      • Chronic Hepatitis C
                        • Marseille CEDEX 08, Bouches-du-Rhone, France
                        • +69 more
                        Mar 13, 2019